Enhancement of the anti-tumor effect of DNA vaccination using an ultrasound-responsive mannose-modified gene carrier in combination with doxorubicin-encapsulated PEGylated liposomes-Reference-Cited by-同舟云学术

Enhancement of the anti-tumor effect of DNA vaccination using an ultrasound-responsive mannose-modified gene carrier in combination with doxorubicin-encapsulated PEGylated liposomes

Published:2014-11 Issue:1-2 Volume:475 Page:401-407
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Yoshida Mitsuru,Kawakami Shigeru,Kono Yusuke,Un Keita,Higuchi Yuriko,Maruyama Kazuo,Yamashita Fumiyoshi,Hashida Mitsuru

Funder

Young Scientists

Scientific Research on Innovative Areas

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference31 articles.

1. Liposomal drug delivery systems: from concept to clinical applications;Allen;Adv. Drug Deliv. Rev.,2013

2. Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer;Antonia;Clin. Cancer Res.,2006

3. Doxil®-the first FDA-approved nano-drug: lessons learned;Barenholz;J. Control. Release,2012

4. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy;Baxevanis;Cancer Immunol. Immunother.,2009

5. Targeted therapies to improve tumor immunotherapy;Begley;Clin. Cancer Res.,2008

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances of ultrasound in tumor immunotherapy;International Immunopharmacology;2024-06

2. Bubble-Based Drug Delivery Systems: Next-Generation Diagnosis to Therapy;Journal of Functional Biomaterials;2023-07-17

3. Utilization of Stimuli-Responsive Biomaterials in the Formulation of Cancer Vaccines;Journal of Functional Biomaterials;2023-04-28

4. Liposomes- A promising strategy for drug delivery in anticancer applications;Journal of Drug Delivery Science and Technology;2022-10

5. Exploring chitosan-shelled nanobubbles to improve HER2 + immunotherapy via dendritic cell targeting;Drug Delivery and Translational Research;2022-06-07